Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Trends in Parasitology|September 14, 2024
RH5: rationally-designed malaria vaccine antigen improving efficacyEizo Takashima, Takafumi Tsuboi
Expert Review of Vaccines|November 13, 2015
Vaccine candidates for malaria: what's new?Eizo Takashima, Masayuki Morita, Takafumi Tsuboi
Parasitology International|December 28, 2024
Ultrastructural expansion microscopy (U-ExM) visualization of malaria parasite dense granules using RESA as a representative marker proteinJunpei Fukumoto, Takafumi Tsuboi, Eizo Takashima
Frontiers in Immunology|February 12, 2026
Identification of a growth-inhibitory epitope in PfRipr5, a malaria vaccine candidate against <i>Plasmodium falciparum</i>Hikaru Nagaoka, Akihisa Fukushima, Takafumi Tsuboi, et al.
Cellular Microbiology|January 10, 2018
A male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasite Plasmodium yoelii (PyMiGS) plays a critical role in male osmiophilic body formation and exflagellationMayumi Tachibana, Tomoko Ishino, Eizo Takashima, et al.
Parasitology International|November 2, 2020
Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine developmentBernard N Kanoi, Hikaru Nagaoka, Masayuki Morita, et al.
Expert Review of Vaccines|June 9, 2025
Advances in transmission-blocking vaccines against <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i>Mayumi Tachibana, Eizo Takashima, Motomi Torii, et al.
Vaccine|March 10, 2020
The C-terminal region of the Plasmodium yoelii microgamete surface antigen PyMiGS induces potent anti-malarial transmission-blocking immunity in miceMayumi Tachibana, Minami Baba, Eizo Takashima, et al.
Frontiers in Cellular and Infection Microbiology|December 17, 2021
Identification of Novel Malaria Transmission-Blocking Vaccine CandidatesEizo Takashima, Mayumi Tachibana, Masayuki Morita, et al.
Expert Review of Vaccines|June 13, 2017
Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidatesEdward H Ntege, Eizo Takashima, Masayuki Morita, et al.
Pageof 25